Prolonged coronavirus outbreak in China could hurt Indian pharma sector

China accounted for 67.56% of total imports of bulk drugs and drug intermediates in 2018-19 at $2,405.42 million.

coronavirus
Press Trust of India New Delhi
2 min read Last Updated : Feb 09 2020 | 11:49 AM IST

Indian pharma firms are closely monitoring the outbreak of coronavirus in China as it could impact the supply of active pharmaceutical ingredients in the country, if the situation in the neighbouring nation does not improve soon.

China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million.

"The situation is being closely monitored by all companies. The government is seized of the issue and all are working in an integrated way to deal with the situation." Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain told PTI.

The areas being looked into are close monitoring of the developments, inventory of critical APIs / intermediates, evaluation of alternate sources where possible and regulatory approvals for environmental clearance for certain APIs where capacity is available, he added.

"India has a high dependence on fermentation-based APIs/ Intermediates namely antibiotics and vitamins. Companies have been maintaining 2-3 months inventory of these APIs and Intermediates," Jain said.

In similar vein, a Sanofi India spokesperson said: "It is too soon to predict any impact that the coronavirus outbreak might have. We are closely monitoring the situation to ensure we have no discontinuity in supply."

India imports bulk drugs/active pharmaceutical ingredients (APIs) for producing medicines including certain essential medicines from China.

The government has earlier said most of the imports of the bulk drugs and APIs are being done because of economic considerations.

On the governmental front, India has cancelled all visas issued to foreign nationals coming from China as it stepped up efforts to combat the spread of coronavirus after 150 passengers were identified with symptoms of the deadly virus and sent to isolation units.

It has also stepped up screening of passengers at 21 airports as well as 12 major seaports and all minor ports.

The government has directed all 12 major ports to immediately put in place screening, detection and quarantine system for disembarking seafarers and cruise passengers as a preventive measure against the coronavirus outbreak.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusIndian pharmaIndian Pharmaceuticals Industry

First Published: Feb 09 2020 | 11:22 AM IST

Next Story